Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced/metastatic solid tumors.

被引：22
|
作者：
Gomez-Roca, Carlos Alberto
Cassier, Philippe Alexandre
Italiano, Antoine
Cannarile, Michael
Ries, Carola
Brillouet, Anne
Mueller, Claudia
Jegg, Anna-Maria
Meneses-Lorente, Georgina
Baehner, Monika
Abiraj, Keelara
Loirat, Delphine
Toulmonde, Maud
D'Angelo, Sandra P.
Weber, Kristy
Campone, Mario
Ruettinger, Dominik
Blay, Jean-Yves
Delord, Jean-Pierre
Le Tourneau, Christophe
机构：
[1] Inst Claudius Regaud, Dept Med, Toulouse, France
[2] Ctr Leon Berard, Dept Med, F-69373 Lyon, France
[3] CLCC Inst Bergonie, Bordeaux, France
[4] Roche Pharma Res & Early Dev Oncol, Penzberg, Germany
[5] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Penzberg, Penzberg, Germany
[6] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Basel, Basel, Switzerland
[7] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Welwyn, Welwyn Garden City, England
[8] Inst Curie, Dept Med Oncol, Paris, France
[9] Inst Bergonie, Dept Med Oncol, Bordeaux, France
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[11] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA
[12] Canc Inst West ICO, Nantes, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.3005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3005
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Phase I study of MEDI0639 in patients with advanced solid tumors.
    Falchook, Gerald Steven
    Dowlati, Afshin
    Naing, Aung
    Gribbin, Matthew Joseph
    Jenkins, David William
    Chang, Linda L.
    Lai, Dominic W.
    Smith, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] A phase I study of lenalidomide and weekly docetaxel in patients with advanced solid tumors.
    Papadopoulos, K
    Mendelson, D
    Preston, GG
    Lopez, AM
    Ricart, AD
    Schwartz, G
    Needle, MN
    Gordon, MS
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9116S - 9116S
  • [24] Phase I study of sequential sapacitabine and seliciclib in patients with advanced solid tumors.
    Shapiro, Geoffrey
    Kwak, Eunice Lee
    Cleary, James M.
    Tolaney, Sara
    Gandhi, Leena
    Clark, Jeffrey W.
    Wolanski, Andrew
    Frame, Sheelagh
    Rodig, Scott J.
    Chiao, Judy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] A phase 2, multiarm study of anti-CD47 antibody, magrolimab, in combination with docetaxel in patients with locally advanced or metastatic solid tumors.
    Subbiah, Vivek
    Vaishampayan, Ulka N.
    Puri, Sonam
    Lin, Lanjia
    Chao, Mark
    Ramsingh, Giri
    Kummar, Shivaani
    Strauss, James F.
    Patel, Sandip P.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [26] A phase I study of a novel IAP inhibitor APG-1387 in patients with advanced solid tumors.
    Xu, Ruihua
    Li, Yuhong
    Ji, Jiao
    Qiu, Miaozhen
    Zhang, Yang
    Liu, Wenqin
    Tian, Xiaohong
    Li, Su
    Wang, Hengbang
    Wang, Fenghua
    Zhang, Dongsheng
    Wang, Feng
    Wang, Zhiqiang
    Luo, Huiyan
    Zou, Benyan
    Wang, De shen
    Ren, Chao
    Jin, Ying
    Zhai, Yifan
    Yang, Dajun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Phase I study of regorafenib and sildenafil in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Gordon, Sarah W.
    McGuire, William P.
    Thacker, Leroy R.
    Deng, Xiaoyan
    Tombes, Mary Beth
    Shrader, Ellen
    Ryan, Alison A.
    Kmieciak, Maciej
    Dent, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Phase I study of pemetrexed and sorafenib in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Shafer, Danielle A.
    Roberts, John D.
    Geyer, Charles E.
    Dent, Paul
    Moran, Richard
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Kathryn
    Wan, Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] A phase I study of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic tumors.
    Gordon, Michael S.
    Hamid, Omid
    Powderly, John
    Anderson, Maria
    Fine, Gregg
    Mokatrin, Ahmad
    Kowanetz, Marcin
    Maya, Leabman
    Irving, Bryan A.
    Chen, Daniel S.
    Hodi, F. Stephen
    CANCER RESEARCH, 2013, 73 (08)
  • [30] A phase I study of LY3022855, a colony stimulating factor-1 receptor (CSF-1 R) inhibitor in patients (pts) with advanced solid tumors.
    Dowlati, Afshin
    Rugo, Hope S.
    Harvey, R. Donald
    Kudchadkar, Ragini Reiney
    Carvajal, Richard D.
    Manji, Gulam Abbas
    Hamid, Omid
    Klempner, Samuel Jacob
    Tang, Shande
    Yu, Danni
    Kauh, John S.
    Schaer, David Arlen
    Tate, Sonya Catherine
    Wesolowski, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345